Rie Shimizu, Kenichi Suda, Toshiki Takemoto, Shota Fukuda, Masato Chiba, Masaki Shimoji, Junichi Soh, Tetsuya Mitsudomi, Yasuhiro Tsutani. A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulation. Surgical case reports. 2024. 10. 1. 49-49
Akira Hamada, Kenichi Suda, Masaya Nishino, Keiko Obata, Hana Oiki, Tomoyo Fukami, Shota Fukuda, Toshio Fujino, Shuta Ohara, Takamasa Koga, et al. Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2024. 19. 1. 71-79
Takamasa Koga, Junichi Soh, Akira Hamada, Yuki Miyano, Toshio Fujino, Keiko Obata, Shuta Ohara, Masaya Nishino, Masato Chiba, Masaki Shimoji, et al. Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing. JTO clinical and research reports. 2023. 4. 9. 100554-100554
Toshio Fujino, Kenichi Suda, Takamasa Koga, Akira Hamada, Shuta Ohara, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, Tetsuya Mitsudomi. Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation. Journal of hematology & oncology. 2022. 15. 1. 79-79
Akira Hamada, Kenichi Suda, Toshio Fujino, Masaya Nishino, Shuta Ohara, Takamasa Koga, Takanobu Kabasawa, Masato Chiba, Masaki Shimoji, Makoto Endoh, et al. Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC. JTO clinical and research reports. 2022. 3. 5. 100321-100321
